# IS-002 Phase 2 Prostate Cancer Study

Source: https://onco.cc/trials/nct05946603/  
OnCo record `nct05946603` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Intraoperative fluorescence and Cerenkov imaging systems in Prostate cancer, run by Intuitive Surgical, completed.

## Summary

IS-002 Phase 2 Prostate Cancer Study is a phase 2 interventional study registered as NCT05946603 by Intuitive Surgical, with 59 participants recorded, started 2023-06-16 and reaching its primary completion in 2024-05-21. Interventions recorded: Administration of IS-002, Firefly fluorescent imaging, robotic-assisted laparoscopic prostatectomy with pelvic lymph node dissection. Conditions recorded: Prostate Cancer.

Linked to the technology Intraoperative fluorescence and Cerenkov imaging systems because the registry names it ("firefly") among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT05946603
- Phase: 2
- Setting: Phase 2 Multi-Center Randomized Controlled Feasibility Study of IS-002 in Subjects Undergoing Robotic-Assisted Radical Prostatectomy Using the da Vinci® Surgical System With Firefly® Fluorescence Imaging
- Sponsor: Intuitive Surgical
- Enrolled: 59

## Sources

- ClinicalTrials.gov NCT05946603: https://clinicaltrials.gov/study/NCT05946603

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- technologies: [Intraoperative fluorescence and Cerenkov imaging systems (SPY, Firefly, LumiSystem, LightPath)](https://onco.cc/technologies/intraoperative-fluorescence-imaging-systems/)
- companies: [Intuitive Surgical](https://onco.cc/companies/intuitive-surgical/)

---
JSON: https://onco.cc/api/v1/entities/nct05946603.json